BioStem Technologies, Inc. ( BSEM) - Key Metrics
BSEM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.46 | -$0.52 | -$0.32 | -$0.32 |
| 2026Q1 | $0.36 | -$0.52 | -$0.05 | -$0.05 |
| 2025Q4 | -$5.07 | -$0.67 | $0.17 | $0.14 |
| 2025Q3 | $0.63 | $0.05 | -$0.14 | -$0.29 |
| 2025Q2 | $2.95 | -$0.03 | $0.32 | $0.30 |
BSEM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.59 |
| 2026Q1 | 0% | -1.94 |
| 2025Q4 | 0% | -1.42 |
| 2025Q3 | 0% | 25.83 |
| 2025Q2 | 0% | -95.04 |
BSEM
Price: $3.54
52 week price:
Earnings Per Share: 0.88 USD
P/E Ratio: 3.65
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 57.2 million